First New York Securities’s Foundation Medicine, Inc. FMI Stock Holding History

First New York Securities’s Portfolio FMI Stock Details FMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3	Closed	-$144	–	591
2015 Q1	$144	Buy	+3	New	+$136	﹤0.01%	372

Other funds holding FMI

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CPM

Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return

First New York Securities's FMI Position: Q2 2015 in Review

First New York Securities sold out of Foundation Medicine, Inc. (FMI) in Q2 2015, closing a stake of 3 shares — an estimated $144 sold.

First New York Securities first reported a position in FMI in Q1 2015 and held it in 1 quarter. The position peaked at $144 in Q1 2015. 96 funds tracked by Wall St. Rank hold FMI as of Q2 2015.

First New York Securities reported no remaining Foundation Medicine, Inc. position as of Q2 2015 after selling out during the quarter.
First New York Securities sold 3 Foundation Medicine, Inc. shares in Q2 2015, an estimated $144.
First New York Securities first reported a position in Foundation Medicine, Inc. in Q1 2015 and held it in 1 quarter.
First New York Securities's Foundation Medicine, Inc. position peaked at $144 in Q1 2015.
96 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2015.

Based on First New York Securities's 13F filing for Q2 2015, filed 30 Jul 2015.